On 20 May 2025, Professor Vincent Kelly, Academic Director of the ARC Hub for Therapeutics, participated in the GenAI: From Prototype to Scalable Adoption event at NovaUCD, contributing to discussions on innovation, trust, and real-world adoption of artificial intelligence in regulated and research-driven sectors.
The event, organised by La French Tech Dublin, the France Ireland Chamber of Commerce, and Sia Partners, brought together founders, enterprise leaders, and AI experts to examine one of the most pressing challenges in AI today: how to scale promising generative AI prototypes into enterprise-grade solutions that deliver measurable impact.
Featuring strategic insights from leaders across finance, health, and energy, the session addressed key topics such as governance, the upcoming EU AI Act, and cross-sector collaboration. The evening concluded with networking among innovators, entrepreneurs, and researchers committed to driving responsible and sustainable AI adoption across Europe.